Economic appraisal of antidepressant pha
โ
David A. Sclar; Tracy L. Skaer; Linda M. Robison; Julie K. Stowers
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 57 KB
๐ 1 views
In the United States, an estimated $44 billion is expended annually for the treatment, morbidity, and mortality associated with depression. Domestic and international cost-containment initiatives are mandating a demonstration of value for money defined in terms of a measurable health and/or financia